Posts Tagged ‘ blepharitis ’

InSite Vision Updates Special Protocol Assessment Submission To FDA For Phase 3 Trial Of AzaSite Plus™ And DexaSite™

2011/04/15
By
InSite Vision Incorporated (OTCBB:INSV) today announced that the Company recently received eight minor recommendations regarding its proposed agreement with the U.S...

Full Story →

InSite Vision Awarded Therapeutic Discovery Project Grant for ISV-502 and ISV-303 Clinical Development

2010/11/03
By
ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV), a company developing novel ophthalmic therapeutics, today announced that it will receive $489,000 under the U.S. Government's Qualifying Therapeutic Discovery Project ("QTDP") program.

Full Story →

Archives